Table 1.
Published reports (more than 13 patients) on the efficacies of first-line antibiotics treatment in HP-negative gastric MALT lymphomas.
| Author | Country | N | Stage | CR Rate N (%) |
Median Time to CR: m (Range) |
HP Test | HPE | t(11;18) | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| Nakamura T, et al. |
Japan | 17 | IE: 16 IIE1: 1 |
2 (11.8) | ND | H, RUT, S | A + C + P with/without M |
CR: 1/2(+) Non-CR: 7/15(+) |
[34] |
| Nakamura S, et al. | Japan | 44 | ND | 6 (13.6) | ND | H, C, RUT, UBT, S | A + C + P C + M + P A + M + P |
NA | [35] |
| Stathis et al. | Switzerland | 14 | IE: 9 IIE1: 5 |
5 (35.7) | ND | H, UBT, S | A + C + P, C + M + P, or A + M + P | NA | [36] |
| Asano et al. | Japan | 17 | IE: 15 IIE: 2 |
5 (29.4) | ND | H, RUT, UBT, S | A + C + P (16 pts) Or A + M + P (1 pt) |
CR: 1/2(+), Non-CR: 6/9 (+) |
[37] |
| Raderer et al. | Austria | 13 | IE: 8 IIE1: 5 |
5 (38.5) | 3–36 | H, UBT, S | C + M + P or C + A + P (7 or 14 D) |
CR: 0/5(+), Non-CR: 3/8(+) |
[30] |
| Gong et al. | Korea | 28 | IE: 24 IIE: 1 IV: 3 |
16 (57.1) | 11.5 (10.0–22.3) |
H, RUT, UBT, S | A + C + P 7D or 14 D |
NA | [38] |
| Kuo et al. | Taiwan | 25 | IE: 22 IIE1: 3 |
8 (32.0) | 6.1(1–24) | H, RUT, UBT, S, C |
A + C + P 14 D |
CR: 0/7(+) Non-CR: 6/13 (+) |
[16] |
| Strati et al. | USA | 26 | IE: 26 | 6 (23.1) | 2 (1–6) | H, S | A + C + P or M + C + P; 14 D |
Non-CR: 0/3 | [39] |
Abbreviation: N, number; CR, complete remission; m, month; HP, Helicobacter pylori; HPE, HP eradication; t(11;18), t(11;18)(q21;q21); Ref, reference; ND, non-described; NA, non-analysis; pt, patient. HP examination test: H, histology; RUT, rapid urease test; UBT, urea breath test; S, serological test; C, culture; HPE regimen: A, amoxicillin; C, clarithromycin; M, metronidazole; P, proton-pump inhibitor, including lansoprazole, pantoprazole or esomeprazole for 7 to 14 days (D).